Samsung Biologics boasts top-tier production capacity at BIO International
Pfizer taps Samsung Biologics in manufacturing deals worth $897 million
Samsung Biologics Plans to Accelerate the Opening of its New Fifth Plant
Samsung Biologics' P4 Super Plant, Songdo, South Korea
Samsung Biologics to go big on CDMO at BIO USA 2023
Company News | Newsroom | SAMSUNG BIOLOGICS
Samsung Biologics and TG Therapeutics Expand Collaboration for the Large Scale Manufacture of Ublituximab | World Pharma Today
Samsung Biologics buys Biogen's stake in Samsung Bioepis for $2.3B | BioWorld
Samsung Biologics' P4 Super Plant, Songdo, South Korea
Pfizer and Samsung Biologics ink biosimilars manufacturing deal
Samsung Biologics set to start construction of Plant 5
Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
Samsung Biologics | The Leading Global CDMO with End-to-End Services
Samsung Biologics Aims to Create Super-wide Gap in CDMO Field - Businesskorea
Samsung Biologics | Incheon
IPO puts value of Samsung BioLogics at $8.2B | Fierce Pharma
Samsung BioLogics: The story of the world's largest biologics manufacturing facility
Our Story | Newsroom | SAMSUNG BIOLOGICS
Samsung Biologics reports an 18.8-percent rise in net profit
Samsung Biologics Customer Story | SailPoint
Samsung Biologics seals $411million long-term contract with Pfizer < Pharma < Article - KBR
Samsung Biologics to double production by 2032; eyes ADCs, M&As - KED Global
![Bio USA] Samsung Biologics seeks giant leap with new plant, ADC tech](http://res.heraldm.com/content/image/2023/06/06/20230606000194_0.jpg "Bio USA] Samsung Biologics seeks giant leap with new plant, ADC tech")
Bio USA] Samsung Biologics seeks giant leap with new plant, ADC tech
Our Story | Newsroom | SAMSUNG BIOLOGICS
Samsung BioLogics Plant 3 Starts Production
Samsung Biologics' focused approach pays off in 2020 - KED Global
Company News | Newsroom | SAMSUNG BIOLOGICS
